文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction.

作者信息

Kerzner Roger, Gage Brian F, Freedland Kenneth E, Rich Michael W

机构信息

Department of Medicine, Washington University School of Medicine, St Louis, Mo 63110, USA.

出版信息

Am Heart J. 2003 Aug;146(2):286-90. doi: 10.1016/S0002-8703(03)00151-0.


DOI:10.1016/S0002-8703(03)00151-0
PMID:12891197
Abstract

BACKGROUND: Although half of elderly patients with heart failure have preserved left ventricular ejection fraction (LVEF), little is known about predictors of mortality in this group. METHODS: We reviewed the charts of 400 patients hospitalized at an academic medical center in 1999 with a principal discharge diagnosis of heart failure. Patients were divided into 4 groups on the basis of age > or =75 or <75 years and the presence of preserved or reduced LVEF. Vital status was ascertained as of October 2001. RESULTS: A total of 373 patients (mean age 69.1 years, 56.0% female, 47.5% nonwhite) underwent echocardiography to assess LVEF. Of these, 216 patients were <75 years of age (81 with preserved LVEF [group 1, 21.7%] and 135 with reduced LVEF [group 2, 36.2%]), and 157 were > or =75 years of age (81 with preserved LVEF [group 3, 21.7%] and 76 with reduced LVEF [group 4, 19.6%]). After a mean follow-up of 25 months, independent predictors of mortality among the 4 groups differed substantially: group 1, male sex, prescription of a calcium-channel blocker, and diuretic dose at discharge; group 2, blood urea nitrogen (BUN), lower hemoglobin level, and not being prescribed a beta-blocker at discharge; group 3, BUN; and group 4, older age, history of myocardial infarction, severity of reduced LVEF, and diuretic dose. CONCLUSION: In patients with heart failure, predictors of mortality vary by age and by the presence of preserved or reduced LVEF. Traditional predictors of mortality in patients with reduced LVEF may not apply to elderly patients with preserved LVEF.

摘要

相似文献

[1]
Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction.

Am Heart J. 2003-8

[2]
Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients.

J Card Fail. 2003-4

[3]
Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.

Int J Cardiol. 2007-6-12

[4]
Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.

J Cardiovasc Med (Hagerstown). 2008-10

[5]
Heart failure with preserved versus reduced left ventricular systolic function: a prospective cohort of Shinken Database 2004-2005.

J Cardiol. 2009-12-21

[6]
Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.

Ital Heart J. 2002-11

[7]
[Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006-4

[8]
[Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure].

Pol Merkur Lekarski. 2006-3

[9]
[Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].

Rev Esp Cardiol. 2004-1

[10]
Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction.

Am Heart J. 2007-6

引用本文的文献

[1]
The Prognostic Significance of the Pan-Immune-Inflammation Value in Patients with Heart Failure with Reduced Ejection Fraction.

Diagnostics (Basel). 2025-6-25

[2]
Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year.

Cardiovasc Ther. 2022

[3]
Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.

Clin Res Cardiol. 2019-4-12

[4]
Mortality in heart failure patients.

Anatol J Cardiol. 2015-1

[5]
FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics.

Clin Cardiol. 2014-12

[6]
Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).

Am J Cardiol. 2014-12-15

[7]
Association of renal biochemical parameters with left ventricular diastolic dysfunction in a community-based elderly population in China: a cross-sectional study.

PLoS One. 2014-2-12

[8]
Prognostic value of resting pulmonary function in heart failure.

Clin Med Insights Circ Respir Pulm Med. 2013-9-5

[9]
Exercise capacity is the most powerful predictor of 2-year mortality in patients with left ventricular systolic dysfunction.

Herz. 2010-3

[10]
Geriatric conditions and subsequent mortality in older patients with heart failure.

J Am Coll Cardiol. 2010-1-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索